LAM RESEARCH CORP (LRCX) Options Risk Score

Run a full LRCX options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on LAM RESEARCH CORP (LRCX) right now?

Over a 4-week expiry window, LAM RESEARCH CORP (LRCX) scores 55 out of 100 for options catalyst risk (MEDIUM). What pushes it there: an upcoming earnings report, 11 recent news items, 1 active legal filing and 1 recent SEC event, all landing inside the 4-week window. A mid-range score (45–69) means LRCX is neither clear nor obviously dangerous over this window — check which specific date is driving it before choosing a strike. The number reflects event exposure only.

LRCX shows an IV Rank of 46, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 65%. IV Rank is the most useful figure for deciding whether to sell or buy premium on LRCX.

The 2026-10-21 earnings report sits inside a standard monthly expiry for LRCX, so implied volatility should stay bid into the date and drop sharply once it passes; the stock has moved up 5.0% recently.

LAM RESEARCH CORP (LRCX) current implied volatility and IV Rank

As of the latest scan, LAM RESEARCH CORP (LRCX) shows an IV Rank of 46 with implied volatility around 65%, alongside a TickerRisk options-risk score of 55/100. That's moderate — options are fairly priced versus the past year, so there's no strong volatility edge in either direction right now; trade the direction, not the vol.

For what this number does and does not tell you about LRCX's options, see IV Rank explained.

LAM RESEARCH CORP (LRCX) next earnings date — 2026-10-21

LAM RESEARCH CORP (LRCX) reports earnings on 2026-10-21 — about 45 days away, which falls inside a typical options expiry window. LRCX's IV Rank is currently 46. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer